Acne vulgaris is a common chronic inflammatory skin disease that mainly occurs in adolescents. Currently, topical antibiotics and retinoids are used as the first-line treatment of mild-to-moderate acne vulgaris, but the side effects of retinoids, such as teratogenicity, dryness of the skin and mucous membranes, desquamation, muscle pain, 1 and the more commonly observed drug resistance related to antibiotics, 2 have limited their clinical application. Phototherapy, including red and blue light therapy, intense pulsed light (IPL) therapy, laser therapy, and photodynamic therapy (PDT), was developed to alleviate the side effect and increase the effectiveness. Light-emitting diode (LED) red and blue light have been officially approved for the treatment of mild-to-moderate acne vulgaris by the FDA in 2009, and it is also recommended for the treatment of moderate acne vulgaris by the acne guideline in China. 3 The therapeutic effect of red